| Attributes | Values |
|---|
| rdf:type
| |
| description
| - wetenschappelijk artikel (nl)
- наукова стаття, опублікована в червні 1996 (uk)
- im Juni 1996 veröffentlichter wissenschaftlicher Artikel (de)
- artículu científicu espublizáu en xunu de 1996 (ast)
- scientific article published on 01 June 1996 (en)
|
| publication date
| |
| publication date
| |
| author name string
| |
| author name string
| - L Edelstein
- M L Aisen
- D Sevilla
- J Blass
|
| rdfs:label
| - A double-blind placebo-controlled study of 3,4-diaminopyridine in amytrophic lateral sclerosis patients on a rehabilitation unit (en)
- A double-blind placebo-controlled study of 3,4-diaminopyridine in amytrophic lateral sclerosis patients on a rehabilitation unit (nl)
|
| skos:prefLabel
| - A double-blind placebo-controlled study of 3,4-diaminopyridine in amytrophic lateral sclerosis patients on a rehabilitation unit (en)
- A double-blind placebo-controlled study of 3,4-diaminopyridine in amytrophic lateral sclerosis patients on a rehabilitation unit (nl)
|
| name
| - A double-blind placebo-controlled study of 3,4-diaminopyridine in amytrophic lateral sclerosis patients on a rehabilitation unit (en)
- A double-blind placebo-controlled study of 3,4-diaminopyridine in amytrophic lateral sclerosis patients on a rehabilitation unit (nl)
|
| title
| |
| title
| - A double-blind placebo-controlled study of 3,4-diaminopyridine in amytrophic lateral sclerosis patients on a rehabilitation unit (en)
|
| page(s)
| |
| page(s)
| |
| instance of
| |
| instance of
| |
| main subject
| |
| main subject
| |
| PubMed ID
| |
| PubMed ID
| |
| PubMed ID
| |
| published in
| |
| published in
| |
| issue
| |
| volume
| |
| issue
| |
| volume
| |
| DOI
| |
| DOI
| |
| DOI
| - 10.1016/0022-510X(96)00012-3
|
| is about
of | |
| is cites work
of | - Efficacy of 3,4-diaminopyridine and pyridostigmine in the treatment of Lambert-Eaton myasthenic syndrome: a randomized, double-blind, placebo-controlled, crossover study.
- Progress in clinical neurosciences: the evidence for ALS as a multisystems disorder of limited phenotypic expression.
- 3,4-diaminopyridine safety in clinical practice: an observational, retrospective cohort study.
- The basic aspects of therapeutics in amyotrophic lateral sclerosis
- Measurement of decline of functioning in persons with amyotrophic lateral sclerosis: Responsiveness and possible applications of the Functional Independence Measure, Barthel Index, Rehabilitation Activities Profile and Frenchay Activities Index
- Amyotrophic lateral sclerosis: progress and prospects for treatment
- Amyotrophic Lateral Sclerosis
- Chapter 21 Disease-Modifying Therapies in Motor Neuron Disorders: The Present Position and Potential Future Developments
- Preparation of 3,4-diaminopyridine microparticles by solvent-evaporation methods
- Clinical trials: the past, a lesson for the future.
|
| is cites work
of | |
![[RDF Data]](/fct/images/sw-rdf-blue.png)
![[cxml]](/fct/images/cxml_doc.png)
![[csv]](/fct/images/csv_doc.png)
![[text]](/fct/images/ntriples_doc.png)
![[turtle]](/fct/images/n3turtle_doc.png)
![[ld+json]](/fct/images/jsonld_doc.png)
![[rdf+json]](/fct/images/json_doc.png)
![[rdf+xml]](/fct/images/xml_doc.png)
![[atom+xml]](/fct/images/atom_doc.png)
![[html]](/fct/images/html_doc.png)